New Delhi, Dec. 11 -- India's expanding health-tech ecosystem continues to attract investor confidence as Inito raises $29 million in Series B funding, led byBertelsmann India Investments (BII)with participation from existing backerFireside Ventures. The Bengaluru-based startup, known for its AI-powered fertility monitoring system, is now setting its sights on the broader horizon ofAI-engineered hormone and health diagnostics.

Founded with the mission to simplify healthcare through at-home testing, Inito plans to leverage the new funding to build a platform capable ofclinical-grade hormone assessmentsfor various health conditions beyond fertility. This round brings its total funding to$45 million, signaling a growing investor interest in...